EP 4031122 A4 20230830 - EFFERVESCENT TABLET FORMULATIONS COMPRISING DAPAGLIFLOZIN AND METFORMIN

Title (en)

EFFERVESCENT TABLET FORMULATIONS COMPRISING DAPAGLIFLOZIN AND METFORMIN

Title (de)

BRAUSETABLETTENFORMULIERUNGEN MIT DAPAGLIFLOZIN UND METFORMIN

Title (fr)

FORMULATIONS DE COMPRIMÉS EFFERVESCENTS COMPRENANT DE LA DAPAGLIFLOZINE ET DE LA METFORMINE

Publication

EP 4031122 A4 20230830 (EN)

Application

EP 20866500 A 20200805

Priority

TR 201914043 A 20190916
TR 2020050687 W 20200805

Abstract (en)

[origin: WO2021054912A1] The invention relates to effervescent tablet formulations comprising dapagliflozin or a pharmaceutically acceptable salt thereof and metformin or a pharmaceutically acceptable salt thereof.

IPC 8 full level

A61K 31/155 (2006.01); A61K 9/20 (2006.01); A61K 31/351 (2006.01); A61P 3/10 (2006.01)

CPC (source: EP)

A61K 9/0007 (2013.01); A61K 31/155 (2013.01); A61K 31/70 (2013.01); A61P 3/10 (2018.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2031 (2013.01)

C-Set (source: EP)

Citation (search report)

[XYI] WO 2017098481 A1 20170615 - STEERLIFE INDIA PRIVATE LTD [IN]
[XY] US 2015238421 A1 20150827 - ABEBE ADMASSU [US], et al
[A] WO 2018185669 A1 20181011 - ZENVISION PHARMA LLP [IN]
See also references of WO 2021054912A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2021054912 A1 20210325; EP 4031122 A1 20220727; EP 4031122 A4 20230830; TR 201914043 A1 20210421

DOCDB simple family (application)

TR 2020050687 W 20200805; EP 20866500 A 20200805; TR 201914043 A 20190916